[FORM 10-K (Mark One) December 31, 2012 For the fiscal year ended: For the transition period from ____________to _____________ Commission File No. 001-34566 CHINA BIOLOGIC PRODUCTS, INC. Delaware 75-2308816 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 18th Floor, Jialong International Building, 19 Chaoyang Park Road (+86) 10-6598-3111 Title of each class Name of each exchange] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in registration statements (No. 333-171069 and 333-182624) on Form S-3 and the registration statement (No. 333-151263) on Form S-8 of China Biologic Products, Inc. of our reports dated March 13, 2013, with respect to the consolidated balance sheets of China Biologic Products,] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Ming Yang, certify that: 1. I have reviewed this annual report on Form 10-K of China Biologic Products, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th] [1. 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. th Ming Yang (Principal Financial and Accounting Officer)]

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): December 24, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) People’s Republic of China 18th Floor, Jialong International Building 86-10-6598-3166 (Former name or former address, if changed since last report) _______________________________________________ see ITEM]

[CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES ____________________________________________________________ 1. He is the duly elected and acting Chief Executive Officer of China Biologic Products, Inc., a Delaware corporation (the “ Corporation ”). Board Preferred Stock ”), of the Corporation designated as Series A Participating Preferred Stock: RESOLVED Charter ”), the Board does hereby provide for the issuance of a series] [PREFERRED SHARES RIGHTS AGREEMENT Dated as of November 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. and SECURITIES TRANSFER CORPORATION as Rights Agent TABLE OF CONTENTS Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 11 12 Section 6. Transfer, Split Up, Combination and Exchange] [CHINA BIOLOGIC PRODUCTS, INC. ADOPTS STOCKHOLDER RIGHTS PLAN The stockholder rights plan, which has a term of two years, is designed to guard against partial tender offers and other coercive tactics to gain control or undue influence of China Biologic without offering a fair and adequate price and terms to China Biologic’s stockholders. The plan does not prevent China Biologic’s] [FORM 8-K Current Report Date of Report (Date of earliest event reported): CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction (I.R.S. Employer Identification No.) 18th Floor, Jialong International Building 19 Chaoyang Park Road 86-10-6698-3166 (Former name or address, if changed since last report) Item 1.01. Entry into a Material Definitive Agreement. On November 19, 2012, the Board]

[FOR RELEASE November 8, 2012 China Biologic Reports Financial Results for the Third Quarter and First Nine Months of 2012 3Q12 Total Sales Up 28.6% to $53.1 Million BEIJING, China – November 8, 2012 – Third Quarter 2012 Financial Highlights Total sales Gross profit Income from operations Net income attributable to the Company Non-GAAP adjusted net income attributable to the] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 8, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6698-3166 (Former name or former address,]